Ret and trk proto-oncogene activation in thyroid papillary carcinomas in French patients from the Champagne-Ardenne region

被引:31
|
作者
Delvincourt, C
Patey, M
Flament, JB
Suarez, HG
Larbre, H
Jardillier, JC
Delisle, MJ
机构
[1] CHU,F-51096 REIMS,FRANCE
[2] CNRS,INST RECH SCI CANC,F-94802 VILLEJUIF,FRANCE
关键词
proto-oncogene activation; ret; trh; thyroid carcinoma;
D O I
10.1016/0009-9120(96)00006-9
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Objectives: To investigate the presence of ret and trk protooncogene rearrangements in thyroid tumors. Design and Methods: High-molecular-weight DNA was extracted from 36 thyroid tumors (1 multinodular goiter, 14 follicular adenomas, 16 papillary carcinomas, 1 lymph node metastasis of a papillary carcinoma, 1 follicular carcinoma, and 3 medullary carcinomas) and 22 adjacent tissues. Southern blot analysis was performed after digestion with EcoR1 or BamH1, using specific probes for ret and trk. Results: Only 2 ret rearrangements were found in 2 papillary carcinomas (overall frequency: 6%; papillary carcinoma frequency: 13%). All normal or tumor samples were negative for the presence of a trk rearrangement. Conclusions: The previous data from the literature are highly conflicting, ranging from 0 to 30% of activation. Our results could be, therefore, classified as medium between these extreme values. It seems, therefore, that genetic and/or geographical factors could play a role in ret and trk proto-oncogene activation.
引用
收藏
页码:267 / 271
页数:5
相关论文
共 50 条
  • [41] A DHPLC protocol for detecting RET proto-oncogene mutations in MEN2 patients and medullary thyroid carcinoma.
    Torrente, I
    De Luca, A
    Conte, C
    Mangino, M
    Chiefari, E
    Arturi, F
    Filetti, S
    Novelli, G
    Dallapiccola, B
    AMERICAN JOURNAL OF HUMAN GENETICS, 2001, 69 (04) : 442 - 442
  • [42] Novel germline RET proto-oncogene mutations associated with medullary thyroid carcinoma (MTC): mutation analysis in Japanese patients with MTC
    Yutaka Kitamura
    Paul J Goodfellow
    Kazuo Shimizu
    Mistuji Nagahama
    Kunihiko Ito
    Wataru Kitagawa
    Hiroki Akasu
    Hiroshi Takami
    Shigeo Tanaka
    Samuel A Wells Jr
    Oncogene, 1997, 14 : 3103 - 3106
  • [43] Novel germline RET proto-oncogene mutations associated with medullary thyroid carcinoma (MTC): Mutation analysis in Japanese patients with MTC
    Kitamura, Y
    Goodfellow, PJ
    Shimizu, K
    Nagahama, M
    Ito, K
    Kitagawa, W
    Akasu, H
    Takami, H
    Tanaka, S
    Wells, SA
    ONCOGENE, 1997, 14 (25) : 3103 - 3106
  • [44] Natural history of medullary thyroid carcinoma in MEN 2 patients carrying a variant at codon 804 in the RET proto-oncogene: A study by the French Neuroendocrine Tumor Group (GTE)
    Suteaua, Valentine
    Lebeaulta, Maylis
    Schlumbergerb, Martin
    Zalzalic, Mohamed
    Lasolled, Helene
    Le Brase, Maelle
    Chabrierf, Gerard
    Raingeardg, Isabelle
    Castinettih, Frederic
    Caroni, Philippe
    Ghanderj, Cecile
    Chevalierk, Nicolas
    Mirebeau-Prunierl, Delphine
    Rohmera, Vincent
    Rodiena, Patrice
    Brieta, Claire
    ANNALES D ENDOCRINOLOGIE, 2025, 86 (02)
  • [45] Gene rearrangements in papillary thyroid carcinomas from RET/PTC3 and TRK-T1 transgenic mice
    Heiliger, Katrin Janine
    Vitagliano, Donatello
    Conte, Natalie A.
    Bradley, Allan
    Unger, Kristian
    Santoro, Massimo
    Zitzelsberger, Horst
    CELLULAR ONCOLOGY, 2007, 29 (02) : 143 - 144
  • [46] Mutation of RET proto-oncogene in Japanese patients with multiple endocrine neoplasia type 2B and sporadic medullary thyroid carcinoma
    Migita, M
    Hiromatsu, Y
    Sato, M
    Yang, D
    Kameo, J
    Jimi, A
    Nonaka, K
    ENDOCRINE JOURNAL, 1997, 44 (04) : 559 - 565
  • [47] Haplotype Frequency of G691S/S904S in the RET Proto-Oncogene in Patients with Medullary Thyroid Carcinoma
    Sheikholeslami, Sara
    Yeganeh, Marjan Zarif
    Rad, Laleh Hoghooghi
    Ghadaksaz, Hoda Golab
    Hedayati, Mehdi
    IRANIAN JOURNAL OF PUBLIC HEALTH, 2014, 43 (02) : 235 - 240
  • [48] LOW-RATE OF RET PROTOONCOGENE ACTIVATION (PTC/RET(TPC)) IN PAPILLARY THYROID CARCINOMAS FROM SAUDI-ARABIA
    ZOU, MJ
    SHI, YF
    FARID, NR
    CANCER, 1994, 73 (01) : 176 - 180
  • [49] RET/PTC oncogene activation defines a subset of papillary thyroid carcinomas lacking evidence of progression to poorly differentiated or undifferentiated tumor phenotypes
    Tallini, G
    Santoro, M
    Helie, M
    Carlomagno, F
    Salvatore, G
    Chiappetta, G
    Carcangiu, ML
    Fusco, A
    CLINICAL CANCER RESEARCH, 1998, 4 (02) : 287 - 294
  • [50] The results of molecular genetic testing for RET proto-oncogene mutations in patients with medullary thyroid carcinoma in a referral center after the two decade period
    Rovcanin, B.
    Damjanovic, S.
    Zivaljevic, V
    Diklic, A.
    Jovanovic, M.
    Paunovic, I
    HIPPOKRATIA, 2016, 20 (03) : 187 - 191